The global cancer vaccines market is expanding due to rising immunotherapy adoption, advancements in personalized medicine, and increasing R&D investments. Demand is driven by growing cancer prevalence and FDA approvals for novel vaccines. Emerging markets show potential, while therapeutic vaccines dominate over preventive ones. Know More: https://www.imarcgroup.com/cancer-vaccines-market